Cargando…

Antifibrotic Effect of a Novel Selective 11β-HSD2 Inhibitor (WZ51) in a rat Model of Myocardial Fibrosis

Myocardial fibrosis (MF) is one of the leading causes of end-stage heart disease. Many studies have confirmed that inflammation caused by aldosterone may play an important role in the process of MF. A selective 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) enzyme inhibitor can reduce the inacti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Fei, Ge, Qin, Qian, Jianchang, Wang, Zhe, Dong, Yaoyao, Chen, Mengchun, Zhang, Xiaodan, Sun, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022133/ https://www.ncbi.nlm.nih.gov/pubmed/33833680 http://dx.doi.org/10.3389/fphar.2021.629818

Ejemplares similares

The Antifibrotic and the Anticarcinogenic Activity of Capsaicin in Hot Chili Pepper in Relation to Oral Submucous Fibrosis
por: Huang, Zoufang, et al.
Publicado: (2022)

Antifibrotic Mechanism of Cinobufagin in Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Li, Xiaohe, et al.
Publicado: (2019)

Antifibrotic Mechanism of Piceatannol in Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Sheng, Hanjing, et al.
Publicado: (2022)

Changes in serum metabolomics in idiopathic pulmonary fibrosis and effect of approved antifibrotic medication
por: Seeliger, Benjamin, et al.
Publicado: (2022)

Antifibrotic Effects of a Barbituric Acid Derivative on Liver Fibrosis by Blocking the NF-κB Signaling Pathway in Hepatic Stellate Cells
por: Wang, Yuan-Hsi, et al.
Publicado: (2020)

ANTIFIBROTIC THERAPY IN IDIOPATHIC PULMONARY FIBROSIS
por: Scullion, T., et al.
Publicado: (2017)

Antifibrotic therapies to control cardiac fibrosis
por: Fan, Zhaobo, et al.
Publicado: (2016)

Drugs for treating myocardial fibrosis
por: Ren, Zhanhong, et al.
Publicado: (2023)

Treatment of myocardial interstitial fibrosis in pathological myocardial hypertrophy
por: Zhu, Fuyu, et al.
Publicado: (2022)

Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of Serelaxin
por: Wetzl, Veronika, et al.
Publicado: (2016)

Antifibrotic and Regenerative Effects of Treamid in Pulmonary Fibrosis
por: Skurikhin, Evgenii, et al.
Publicado: (2020)

11β-HSD Types 1 and 2 in the Songbird Brain
por: Rensel, Michelle A., et al.
Publicado: (2018)

Rhein, a novel Histone Deacetylase (HDAC) inhibitor with antifibrotic potency in human myocardial fibrosis
por: Barbosa, David Monteiro, et al.
Publicado: (2020)

TNFα-mediated Hsd11b1 binding of NF-κB p65 is associated with suppression of 11β-HSD1 in muscle
por: Doig, Craig L, et al.
Publicado: (2014)

Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies
por: Ismail, Mona H, et al.
Publicado: (2011)

HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis
por: Lyu, Xing, et al.
Publicado: (2019)

Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
por: Maher, Toby M., et al.
Publicado: (2019)

Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis
por: Sugino, Keishi, et al.
Publicado: (2021)

Recent Advancements in Antifibrotic Therapies for Regression of Liver Fibrosis
por: Jangra, Anshika, et al.
Publicado: (2022)

Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
por: Li, Ji-Min, et al.
Publicado: (2023)

Yeast-based assays for screening 11β-HSD1 inhibitors
por: Vanella, Rosario, et al.
Publicado: (2016)

Macrophage 11β-HSD-1 deficiency promotes inflammatory angiogenesis
por: Zhang, Zhenguang, et al.
Publicado: (2017)

11β-HSD as a New Target in Pharmacotherapy of Metabolic Diseases
por: Kupczyk, Daria, et al.
Publicado: (2022)

Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention
por: Yin, Xiaoying, et al.
Publicado: (2023)

11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Inhibitors Still Improve Metabolic Phenotype in Male 11β-HSD1 Knockout Mice Suggesting Off-Target Mechanisms
por: Harno, Erika, et al.
Publicado: (2013)

Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
por: Liu, Yuhan, et al.
Publicado: (2023)

11β-HSD1 inhibition ameliorates diabetes-induced cardiomyocyte hypertrophy and cardiac fibrosis through modulation of EGFR activity
por: Zou, Chunpeng, et al.
Publicado: (2017)

Synthesis of Novel 2-(Isopropylamino)thiazol-4(5H)-one Derivatives and Their Inhibitory Activity of 11β-HSD1 and 11β-HSD2 in Aspect of Carcinogenesis Prevention
por: Kupczyk, Daria, et al.
Publicado: (2020)

Lcz696 Alleviates Myocardial Fibrosis After Myocardial Infarction Through the sFRP-1/Wnt/β-Catenin Signaling Pathway
por: Liu, Jing, et al.
Publicado: (2021)

Research Progress of Traditional Chinese Medicine in Treatment of Myocardial fibrosis
por: Ren, Chunzhen, et al.
Publicado: (2022)

Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-β–Smad3 Pathway
por: Wang, Yinhui, et al.
Publicado: (2021)

Getting to the heart of intracellular glucocorticoid regeneration: 11β-HSD1 in the myocardium
por: Gray, Gillian A, et al.
Publicado: (2016)

Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism
por: Morgan, Stuart A, et al.
Publicado: (2016)

Inhibition of 11β-HSD1 by Tetracyclic Triterpenoids from Euphorbia kansui
por: Guo, Jie, et al.
Publicado: (2012)

Does the Caesarean Section Impact on 11β HSD2 and Fetal Cortisol?
por: Słabuszewska-Jóżwiak, Aneta, et al.
Publicado: (2020)

Equisetin is an anti-obesity candidate through targeting 11β-HSD1
por: Xu, Zhenlu, et al.
Publicado: (2022)

Antifibrotic effects of crocin on thioacetamide-induced liver fibrosis in mice
por: Algandaby, Mardi M.
Publicado: (2018)

Antifibrotic role of vascular endothelial growth factor in pulmonary fibrosis
por: Murray, Lynne A., et al.
Publicado: (2017)

Antifibrotic Effect of Marine Ovothiol in an In Vivo Model of Liver Fibrosis
por: Brancaccio, Mariarita, et al.
Publicado: (2018)

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
por: George, Peter M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_st3e2s9c7bq8u9l5ngrgefufr8